High-resolution MR imaging of the arterial wall in moyamoya disease
Min Yuan1, Zhi-qiang Liu1, Zhi-qiang Wang2
1Department of Neurology, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi, China.
Abstract:
High resolution magnetic resonance imaging (HRMRI) has been developed as an emerging tool for evaluating intracranial arterial disease. We aimed to analyze the progression of diseased arterial walls in moyamoya disease (MMD) and further elucidate differences compared to intracranial atherosclerotic stenosis using HRMRI. The population of this HRMRI study consisted of 21 patients with MMD and 44 patients with atherosclerotic middle cerebral artery (MCA) stenosis. The cross-sectional images of the MCA wall on HRMRI were compared between the two groups based on outer diameter, wall thickness, luminal stenotic morphology, signal intensity, collateral vascular structures adjacent to stenotic position. In addition, stage classification based on MRA finding was used to depict the course of moyamoya disease. We compared outer diameter and wall thickness of the MCAs in different MRA stages. As a result, the outer diameter and wall thickness of MCAs were significantly smaller in the MMD group than in the atherosclerosis group (outer diameter: MMD 2.01 ± 0.31 mm vs. atherosclerosis 3.31 ± 0.37 mm, p<0.001 and wall thickness: MMD 0.39 ± 0.19 mm vs. atherosclerosis 1.64 ± 0.38 mm, p < 0.001). The concentric stenosis (91.4% in MMD vs. 36.9% in atherosclerosis group, p < 0.001), homogeneous signal intensity (85.7% in MMD vs. 32.6% in atherosclerosis group, p < 0.001) and collateral vascular structures (54.3% in MMD vs. 8.7% in atherosclerosis group, p < 0.001) were more common in MMD patients. In addition, the outer diameter of MCAs in MMD was significantly different between MRA stage 1 and MRA stage 3 or 4 (MRA stage 1 vs. MRA stage 3, Nemenyi test p = 0.005 and MRA stage 1 vs. MRA stage 4, Nemenyi test p = 0.009). But the wall thickness of MCAs was no significantly different in different MRA stages (Kruskal-wallis H test, p = 0.074). We conclude that HRMRI may be used to identify different types of middle cerebral artery stenosis. MMD was characterized by concentric stenosis, homogeneous signal intensity, and collateral vascular structures in the affected MCA segments by HRMRI. Pathological shrinkage of MCA was an important phenomenon in MMD progression.
Insights
High-resolution MRI distinguishes moyamoya disease (MMD) from atherosclerotic stenosis by revealing smaller, concentrically narrowed middle cerebral arteries (MCAs) with homogeneous signals and collateral vessels in MMD. Pathological shrinkage is key in MMD progression.
Area of Science:
- Neurology
- Radiology
- Vascular Imaging
Background:
- Intracranial arterial diseases require accurate differentiation for effective management.
- High-resolution magnetic resonance imaging (HRMRI) offers advanced visualization of arterial walls.
- Moyamoya disease (MMD) and intracranial atherosclerotic stenosis present distinct pathologies.
Purpose of the Study:
- To analyze arterial wall progression in MMD using HRMRI.
- To differentiate MMD from atherosclerotic middle cerebral artery (MCA) stenosis via HRMRI.
- To correlate HRMRI findings with MRA staging in MMD.
Main Methods:
- HRMRI was used to compare MCA wall characteristics in 21 MMD patients and 44 atherosclerotic stenosis patients.
- Parameters analyzed included outer diameter, wall thickness, stenosis morphology, signal intensity, and collateral vessels.
- MCA dimensions were compared across different MRA stages in MMD patients.
Main Results:
- MCAs in MMD were significantly smaller in outer diameter and wall thickness compared to atherosclerotic stenosis.
- Concentric stenosis, homogeneous signal intensity, and collateral vessels were more prevalent in MMD.
- MCA outer diameter in MMD varied significantly with MRA stages, unlike wall thickness.
Conclusions:
- HRMRI can effectively differentiate MMD from atherosclerotic MCA stenosis.
- MMD is characterized by concentric stenosis, homogeneous signal, and collateral vessels on HRMRI.
- Pathological shrinkage of MCAs is a significant feature of MMD progression.
More Related Videos
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
08:13Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis
Published on: March 22, 2016
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Magnetic Resonance Imaging
